SLS Bio Co., Ltd.

SLS Bio is a South Korean biotechnology company specializing in pharmaceutical quality control (QC), new drug development support, and in-vitro diagnostics. Established in 2007, it has grown into Korea's only comprehensive QC service provider for a wide range of products, including chemical medicines, biopharmaceuticals (vaccines, antibody treatments), and animal drugs. The company is a critical partner for global pharmaceutical firms, handling quality control for high-profile treatments such as the obesity drug Wegovy. The company operates three core business units: Pharmaceutical QC, which serves as its primary revenue driver; New Drug Development Support, which provides efficacy and safety evaluations; and In-vitro Diagnostics, which develops proprietary platforms like NTMD (Nano Technology Multiplex Diagnostic) and NALF (Nucleic Acid Lateral Flow). SLS Bio is currently expanding into the cosmetics and food testing markets to diversify its revenue streams.